Reemergence of the International Normalized Ratio for the Standardization of Prothrombin Time*
|
|
- Rosemary Farmer
- 6 years ago
- Views:
Transcription
1 ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. Reemergence of the International Normalized Ratio for the Standardization of Prothrombin Time* EDWARD E. MORSE, M.D., SOPHIA PANEK, M.S., PATRICIA PISCIOTTO, M.D., THOMAS KIRALY, M.S., ROBERT BONA, M.D.,t KATHLEEN VOSE, MT(ASCP),t and FREDERICK RICKLES, M.D. The University o f Connecticut Health Center, Department o f Laboratory Medicine, Farmington, CT and fst. Francis Hospital and Medical Center, Hematology and Laboratory Medicine, Hartford, CT ABSTRACT A survey of physicians demonstrated that half had knowledge of the International N orm alized Ratio (INR) but none used the value for m onitoring their patients because it was not available from the Coagulation Laboratory. The Laboratory then provided the INR value at a physician s request. A six month review of prothrombin time (PT) results showed that only the physicians from the Cardiology Clinic and the Hematology Clinic employed the INR for monitoring their patients. General Medical and Surgical, Vascular, and O rthopedic Clinics continued to use the PT in seconds. This dichotomy allowed the unique opportunity to compare variability of PT in patients followed by INR and those followed by PT in seconds. Inpatients on daily m onitoring were used as the standard for close control. During a six month period, laboratory reports from all patients having regular PTs and/or INRs recorded were analyzed for mean level of PT maintained, variability betw een individual PTs in any given patient, and instances when the PT changed = 5 seconds (sec) or increased to S20 sec. Physicians intended to keep the PTs between 16 and 19 sec (INR 2.0 to 3.0). Results show ed statistically significantly lower values of PT, less variation in values of PT and a smaller fraction of patients with changes in PT of =5 sec in the group followed by INR. This group was comparable to the inpatient group b u t significantly different from the outpatient group followed by PT in sec. These results suggest that either the INR allows more stable application of coumadin doses, or physicians using the INR educate their patients in better compliance in diet, medications, and other factors affecting coumadin or vitamin K metabolism. Use of the INR does appear to decrease the variability of the PT in patients so followed. The clinical implications are as yet to be determined. * Send reprint requests to: Edward E. Morse, M.D., The University of Connecticut Health Center, Department of Laboratory Medicine, Room C2067A, MC #2225,263 Farmington Avenue, Farmington, CT /93/ $00.90 Institute for Clinical Science, Inc.
2 REEM ERGENCE OF THE INR FOR THE STANDARDIZATION OF PROTHROMBIN TIME* 185 Introduction T he International N orm alized Ratio (INR) is a concept first developed in 1972 and w idely applied in the U nited Kingdom, Europe, and Canada in an attempt to standardize the various preparations of throm boplastins used for determ ining the prothrombin time (PT) in different countries. T he history of this developm ent has been recently review ed.1 In brief, during the 1970s, a cooperative study, organized under the auspices of the International C om m ittee on Standardization in Hematology/International Council on Thrombosis and Hemostasis (IC SH/IC T H) to standardize throm boplastin, developed a m ethod for d eterm ining an International Sensitivity Index (ISI) for each throm boplastin used. The ISI is the activity of any given thromboplastin relative to the World Health Organization (WHO) standard thromboplastin made from hum an brain extract. Results w ere published in 1979,2 and the international community was encouraged to use the INR system. In North America, comm ercial m anufacturers of throm boplastin had developed m ethods for producing rapid and reproducible throm boplastins extracted from rabbit brain, bovine lung, or human placentas, and the pathologists enjoyed the comfort of rapid turnaround time for clinicians and small coefficients of variation (CVs) for proficiency surveys of the College of American Pathologists (CAP). T he latte r system of standardization involved collection of normal and patient plasmas which were more stable in storage and available in larger volumes in contrast to the standardized throm boplastins of the European system.3,6 W hen it became clear that the rapid, b u t less sensitive throm boplastins produced from rabbit brain (ISI of 2.1 to 2.6) w ere more often associated w ith b leed in g e p iso d e s in p a tie n ts re c e iv in g coumarin derivatives as com pared with their European counterparts who were monitored by the more sensitive (ISI 1.1 to 1.6) but variable human brain thromb o p la s tin s,1,5,7 p h y sician s from th e United States reacted by decreasing the doses of coumarin. They aimed for ratios of PT in the range of 1.3 to 1.8 instead of the 2.0 to 2.5 target recom mended when human brain thromboplastins were used. Since no universally accepted hum an brain throm boplastin was readily available in the U nited States and the practical problem was solved, the INR failed to gain a foothold. The Ad Hoc committee of the ICSH/ ICTH continued to improve upon the INR using an increased num ber of standardized normal and coum arin-treated patient plasm as for standardization of throm boplastins.4 Furtherm ore, international travel in creased, not only for patients w ith an expanding variety of throm botic and vascular diseases, but also for sales persons of a burgeoning num ber of manufacturers of coagulation analyzers and reagents. By 1985, the INR was reemerging in Europe and later in America1,7 until in 1991 even the CAP was moved to produce a Q Probe to determine the reasons for the lack of use of the INR in the United States. Stimulated by this Q Probe, the current authors determ ined among physicians treating patients w ith coum arin derivatives in our facility the level of interest in the INR, and our group undertook to compare the results of patients followed by INR with those followed by the traditional methods (seconds or ratio of PT to normal m ean value). Methods The PT was determ ined by automated technique using optical density m easurem ent (Coag-A-Mate).* The throm boplas * Organon Teknika, 100 Akzo Avenue, Durham, NC
3 186 MORSE, PANEK, PISCIOTTO, KIRALY, BONA, VOSE, AND RICKLES tin used for this study was a rabbit brain preparation (Simplastin)* with an ISI 2.2. Normal values were determ ined on citrate t anticoagulated plasm a sam ples from 30 m ale and fem ale laboratory workers. The INR was determ ined as PT of the patient divided by mean normal control PT and the result raised to the power of the ISI. A chart was prepared for the INR values at each 0.5 second interval for quick conversion of m easured PT in seconds to INR if the physician ordered it. Follow ing an announcem ent to all clinics about the availability of the INR, results of patients having PTs m easured at regular intervals (daily inpatient), weekly, or m onthly o u tp atien ts, w ere analyzed. Patients who had at least three PTs determ ined after the INR was applied for monitoring were compared with patients who continued to be m onitored by seconds. Physicians were also surveyed for determ ination of any complications. TABLE I Relationship of Prothrombin Time to the International Normalized Ratio at the University of Connecticut Health Center* PT In Seconds INR PT In Seconds INR Using rabbit brain thromboplastin with an International Sensitivity Index (ISI) of 2.2. PT = prothrombin time. INR = international normalized ratio. Results The questionnaire associated with the CAP Q Probe revealed that of the 10 physicians sampled, half knew of the INR, but none calculated their own values or used the IN R for oral anticoagulant monitoring. Four of ten who answered the questions thought that there was no reluctance on the part of physicians, nor on the part of laboratory staff to im plem ent use of the INR. All of the p h y sician s u se d th e PT in seconds because it was available from the laboratory. All 10 physicians surveyed in d i cated relatively conservative lim its of prolongation of PT used for m onitoring t Becton Dickinson, 383 Hillen Road, Towson, MD th e ir patients, starting as low as 14 seconds with most using 19 seconds as the highest value and only two using upper values of 20 or 22 seconds. Laboratory staff indicated their opinion that technical difficulty m ight be encountered in calculating the INR until an analytical instrum ent that produced results reported as INR was available. Im m ediate implem entation was accomplished by posting table I. Testing normal subjects revealed a mean value for the PT of 11.5 ± 0.75 seconds (95 percent confidence interval 10 to 13 seconds). L aboratory reports w ere exam ined from all patients who had had at least three PTs ordered and who had values of PT greater than 13.0 seconds. Forty-nine inpatients w ere analyzed as a closely m onitored group. Fifty-nine outpatients
4 REEM ERGENCE O F THE INR FOR THE STANDARDIZATION OF PROTHROMBIN TIME 187 follow ed by IN R in C ardiology and Hematology Clinics were compared with 59 outpatients followed by seconds in G eneral M edical and Surgical Clinics (table II). There was a small but statistically significant difference in mean prothrombin time, in the variation betw een individual PTs, and in the proportion of PTs showing a variation of ^ 5 sec betw een the groups. In each of these determinations, the patients followed by INR showed values comparable to the inpatient group of patients. In contrast, the group of outpatients followed by the traditional method (PT in sec) showed small but statistically significantly greater values than either the inpatient group or the INR group in these param eters. Both outpatient groups show ed a statistically greater proportion of patients with PT 20 sec than the closely m onitored inpatient group (table II). Discussion Relatively little resistance to the routine use of the INR in monitoring oral anticoagulation was encountered once physicians ordering the test understood the advantages of its use and the technologists in the laboratory understood the ease of conversion of the PT in seconds to INR. D u rin g th e first six m onths of follow-up, it was clear that the two clinics involved in studies of oral anticoagulant (low dose coumadin) in cardiology and throm bosis tre a tm e n t in hem atology were eager to obtain and use INR data. The general M edical and Surgical C linics, and the Vascular, and O rthopedic Clinics continued to use PT in seconds for monitoring. This dichotomy allowed the examination of levels of PT and of fluctuations (As) betw een values of PT in each set of patients. The inpatient group, which was m onitored on a daily basis with PT in seconds, showed the smallest variation in PT and the lowest proportion of PT g 20 sec. In addition to daily monitoring and coumadin adjustments, inpatients are likely to receive a more uniform diet and have b e tte r co m p lian ce w ith m e d ic a tio n intake since these are provided by a schedule by nurses. Therefore, fluctuation in PT, both in frequency and in magnitude, are likely to be minimized. Taking this group as a standard for comparison, the group followed by INR in the two clinics where a small group of physicians was involved in studies of long-term coum adin effects show ed alm ost identical values for m ean PT, APT, and proportion of PT ^ 5 sec to those of the standard inpatient group. The proportion of PT = 20 sec was statis TABLE II Comparison of Inpatients with Two Groups of Outpatients Treated with Coumarin N m s x PT± SD APT± SD PT>20Sec #A > 5ec IP (Sec) 49 (306) 16.1 ± ± / % 13/ % OP (Sec) 59 (273) 17.2 ± 3.6a 2.93 ± 3.08a 33/273b 12.1% 31/214= 14.5% OP (INR) 59 (308) 16.2 ± 3.0a 1.86 ± 1.75a 34/308d 11.4% 13/249c 5.1% a p < 0.01 NP t Test bp <0.025 X2 Test c p < Y? Test d p NSX2Test p values refer to differences with the group above the symbol.
5 188 MORSE, PANEK, PISCIOTTO, KIRALY, BONA, VOSE, AND RICKLES tically significantly greater than the inpatient group, probably reflecting w ider variations seen in outpatients because of lo n g er (m onthly) in te rv als b e tw e e n determ ination of PT. On the other hand, the outpatients followed by a wider variety of physicians in general clinics using the traditional PT in seconds show ed small but statistically significantly higher PT, APT, and an increased proportion of PT ^ 5 sec compared to the group followed by INR. This suggests a variety of potential differences in practice in the control of the patients in the G eneral M edical and Surgical Clinics relating to dosage of coumadin, com pliance, frequency of follow -up, dietary habits, and other m edications. Use of the INR scale for monitoring may allow few er changes in dosage of coumadin. The physicians using the INR may better educate their patients to the complicating effects of diet (vitamin K content) and other drugs (antibiotics, alcohol); the effects of coumadin being of prim ary im portance to these patients. The patients in the General Clinics, on the other hand, may be different in educational and ethnic background, have different dietary habits, and their physicians may have other priorities (hypertension, diabetes, infections, renal failure, arthritis, to name a few) which modify the emphasis given to oral anticoagulants for what may be view ed as a secondary complication of the prim ary disease. Finally, the clinical significance of the small, b u t statistically significant reduction in variability shown in the group of outpatients followed by INR needs to be evaluated. The data in this study support some of the enthusiastic predictions that INR may allow better control and safer practice.5 There is a statistically significant difference in levels of PT and in APTs betw een the two groups of outpatients w hich m ight b e correlated w ith clinical complications. In an institution w here all the physicians use relatively conservative doses of coum arin derivatives and therapeutic PTs range from 14 to 20 sec (INR 1.5 to 3.4), there appears to be small but statistically significant lower values in PT and in variability of PT when patients are followed by INR. The values were comparable with the closely monitored group of inpatients who have daily measurem ents of PT and adjustment of dose. F u tu re work should include: a prospective random ized study w here coum adin dosages are actively adjusted according to the PT or INR, standardization of the frequency of obtaining PT in patients being followed, and specific d e lin e a tio n of c lin ic a l sig n ific a n ce (bleeding or recurrent thrombosis). The present findings support the obvious value of INR when the patient is having PTs perform ed at different laboratories and may have PTs m easured with m arkedly d iffe re n t th ro m b o p lastin s. There is a clear need for a mechanism to compare research studies from institution to institution and to provide published data which can be interpreted in context around the world. References 1. H i r s h, J.: Oral anticoagulant drugs. New Engl. J. Med. 324: , ICTH/ICSH: Prothrombin time standardization: Report of the expert panel on oral anticoagulant control. Thromb. Haemost. 42: , Ko e p k e, J. A., G il m e r, P. R., T r i p l e t t, D. A., and O SULLIVAN, M. B.: The prediction of prothrombin time system performance using secondary standards. Am. J. Clin. Pathol. 68: , L o e l i g e r, E. A.: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb. Haemost. 54: , M e i e r, F. A. and S c h i f m a n, R. B.: Q Probe: The INR and monitoring of oral anticoagulation. College of American Pathologists, M la LE, J. B. and K e n t, B. A.: Performance characteristics of reference thromboplastins. Am. J. Clin. Pathol. 60: , POLLER, L.: P rogress in standardization in an tic o a g u la n t c o n tr o l. H e m a to l. R ev. 2: , 1987.
HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors in Patients with H unter s Syndrom e*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 5 Copyright 1985, Institute for Clinical Science, Inc. HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors
More informationA Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
ANNALS O F CLINICAL AND LABORATORY SC IEN CE, Vol. 20, No. 1 Copyright 1990, Institute for Clinical Science, Inc. A Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
More informationClinical Trial of Young Red Blood Cells Prepared by Apheresis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 6 Copyright 1986, Institute for Clinical Science, Inc. Clinical Trial of Young Red Blood Cells Prepared by Apheresis PATRICIA PISCIOTTO, M.D.,* THOMAS
More informationSensitivity of Serum Fructosamine in Short Term Glycemic Control
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Sensitivity of Serum Fructosamine in Short Term Glycemic Control
More informationLONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey. Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France
LONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France Prof Ercan Ok Divis ion of N ephrology E ge U nivers ity
More informationControl of Oral Anticoagulant Therapy*
ANNALS O F C L IN IC A L A N D LABORATORY S C IE N C E, Vol. 18, No. 6 Copyright 1988, Institute for Clinical Science, Inc. Control of Oral Anticoagulant Therapy* JAMES J. BIEMER, M.D. St. Joseph s Hospital
More informationResponse of Red Blood Cell Control Materials to Altered Testing Conditions
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 1 Copyright 1988, Institute for Clinical Science, Inc. Response of Red Blood Cell Control Materials to Altered Testing Conditions MARK E. SHERMAN,
More informationHow Good is your INR? The Use of Certified Plasmas in PT/INR Testing. INR System. How Good is your INR? Outline
How Good is your INR? The Use of Certified Plasmas in PT/INR Testing Dot Adcock, MD Esoterix Coagulation Mayo/NASCOLA Coagulation Testing Quality Conference April 25, 2007 How Good is your INR? The Use
More informationViscoelastic Measurement of Clot Formation: A New Test of Platelet Function
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 2 Copyright 1983, Institute for Clinical Science, Inc. Viscoelastic Measurement of Clot Formation: A New Test of Platelet Function ABDUS SALEEM,
More informationE levated Prolactin Level in Prostates with Latent Carcinoma
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 3 Copyright 1987, Institute for Clinical Science, Inc. E levated Prolactin Level in Prostates with Latent Carcinoma RYUICHI YATANI, M.D.,* ITSUO
More informationThyroid Screening in the Newborn: Utah Experience
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 1 Copyright 1983, Institute for Clinical Science, Inc. Thyroid Screening in the Newborn: Utah Experience BRUCE A. BUEHLER. M.D.,* MELVIN J. GORTATOUSKI,
More informationProtein S and Thrombosis*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 3 Copyright 1989, Institute for Clinical Science, Inc. Protein S and Thrombosis* ROBIN L. GRAVES-HOAGLAND, P h.d. and FR ED ER IC K J. WALKER,
More informationNormalised Ratio. Papers. Effect of thromboplastin and coagulometer interaction on the precision of the International
...~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~... J Clin Pathol 1995;48:13-17... Papers Metro-McNair Clinical Laboratories C Filby DWPi Department of Pathology and Laboratory Medicine, University of British
More informationRapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 5 Copyright 1979, Institute for Clinical Science, Inc. Rapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer* STEVEN
More informationH yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 4 Copyright 1985, Institute for Clinical Science, Inc. H yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume Use
More informationControlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in Advanced Parkinson s Disease
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 2 Copyright 1989, Institute for Clinical Science, Inc. Controlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in
More informationCoagulation and Transfusion Medicine
Coagulation and Transfusion Medicine / BLOOD COLLECTION TUBES AND PT Influence of Blood Collection Systems on the Prothrombin Time and International Sensitivity Index Determined With Human and Rabbit Thromboplastin
More informationLOGO. Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University & Thai Society of Clinical Pathology
LOGO Improvement of Coagulation Lab Practice in Thailand via Thailand NEQAS for Blood Coagulation : 4-year Experience Nisarat Opartkiattikul MD,PhD Panutsaya Tientadakul, MD. Department of Clinical Pathology,
More informationStability of prothrombin time and activated partial thromboplastin time tests under different storage conditions
Clinica Chimica Acta 300 (2000) 13 21 www.elsevier.com/ locate/ clinchim Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions L.V. Rao *, A.O.
More informationPlatelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Platelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
More informationThe Effect of Vitamins C and E on Lipid Peroxidation in Stored Erythrocytes*
ANNALS O F CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 1 Copyright 1993, Institute for Clinica! Science, Inc. The Effect of Vitamins C and E on Lipid Peroxidation in Stored Erythrocytes* JOSEPH A. KNIGHT,
More informationAcquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 5 Copyright 1983, Institute for Clinical Science, Inc. Acquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
More informationReappraisal of Thromboplastin
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 11, No. 3 Copyright 1981, Institute for Clinical Science, Inc. Reappraisal of Thromboplastin F. D. ZIEGLER, Ph.D.,* S. A. RICH, Ph.D.,* M. J. FASCO,* CAMERON
More informationAn Assay for Monitoring Response to Therapy in Cancer Patients*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. An Assay for Monitoring Response to Therapy in Cancer Patients* CALVIN C. W ILH ID E, P h.d.tt
More informationA Look at Patient Compliance to INR Testing and Therapeutic Range Management of Patients on Warfarin at Agassiz Medical Center.
A Look at Patient Compliance to INR Testing and Therapeutic Range Management of Patients on Warfarin at Agassiz Medical Center Lauren Martens Abstract This study sought to determine the total number of
More informationEffects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task
Effects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task R obert S. K ennedy*, Janet J. Turnage*, D eborah L. H arm ** and Julie M. Drexler*** *Essex Corporation,
More informationM onitoring of Drugs in Breast Milk
ANNALS O F CLIN IC A L A N D LABORATORY SC IE N C E, Vol. 15, No. 2 Copyright 1985, Institute for Clinical Science, Inc. M onitoring of Drugs in Breast Milk STEVEN H. Y. W ONG, P h.d. Department of Laboratory
More informationLong-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson s Disease*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, 6 Copyright 1989, Institute for Clinical Science, Inc. Long-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson
More informationProblems with Outliers in Breath Alcohol Testing
Problems with Outliers in Breath Alcohol Testing Jo c h e n W ilske Blood alcohol concentration (BAC) and impairment o f driving skills are related so closely, that statutory drink-drive limits are accepted
More informationEFFEC TS O F N O ISE O N C O G N ITIV E PROCESSES O F IN D IV ID U A L S IN A LABORATORY E X PERIM ENT
Polish Journal of Occupational Medicine and Environmental Health Vol. 4, N o 3, 269-279, 1991 EFFEC TS O F N O ISE O N C O G N ITIV E PROCESSES O F IN D IV ID U A L S IN A LABORATORY E X PERIM ENT BO H
More informationThrombosis and Coagulation Abnormalities Associated with Cancer
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 1 Copyright 1994, Institute for Clinical Science, Inc. Thrombosis and Coagulation Abnormalities Associated with Cancer ARMAND B. GLASSMAN, M.D. and
More informationThe study has been approved by Ethics Commission. Informed consent has been given by all participants.
Evaluation of new 9NC Coagulation Tubes Background: Venous blood with sodium citrate is the most commonly obtained examination sample for coagulation determinations. The additive functions as an anticoagulant
More informationNOACS/DOACS*: COAGULATION TESTS
NOACS/DOACS*: COAGULATION TESTS OBJECTIVES: To describe the effect of the newer direct oral anticoagulants (DOACs) on laboratory coagulation tests which are widely available: prothrombin time (PT), international
More informationVitamin K antagonist (VKA) therapy is routinely
International Normalized Ratio Versus Plasma Levels of Coagulation Factors in Patients on Vitamin K Antagonist Therapy Gene Gulati, PhD; Megan Hevelow, MS; Melissa George, DO; Eric Behling, MD; Jamie Siegel,
More informationWhole Blood Viscosity in Beta Thalassemia Minor
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 4 Copyright 1992, Institute for Clinical Science, Inc. Whole Blood Viscosity in Beta Thalassemia Minor JAMES P. CROWLEY, M.D.t, JACLYN B. M ETZGER,
More informationScreening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions
Screening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions C arl A. S o d e r str o m, M.D.,1 P a tricia C. D isc h in g e r, P h.d.,2 G ord on S. S m ith, M.D.3
More informationAssessment of Cellular Immune Response to Cancer of the Breast
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 6 Copyright 1979, Institute for Clinical Science, Inc. Assessment of Cellular Immune Response to Cancer of the Breast RONALD B. HERBERM AN, M.D. Laboratory
More informationU se o f Cerebrospinal Fluid Lactic Acid Concentration in the Diagnosis of Fungal M eningitis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 6 Copyright 1987, Institute for Clinical Science, Inc. U se o f Cerebrospinal Fluid Lactic Acid Concentration in the Diagnosis of Fungal M eningitis
More informationClinical Correlates in Patients with Elevated Platelet-Associated Immunoglobulins*!"
ANNALS O F CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 1 Copyright 1988, Institute for Clinical Science, Inc. Clinical Correlates in Patients with Elevated Platelet-Associated Immunoglobulins*!" MARK
More informationAssessment of Results of Estrogen and Progesterone Receptor Assays Performed in a Community Hospital
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 4 Copyright 1986, Institute for Clinical Science, Inc. Assessment of Results of Estrogen and Progesterone Receptor Assays Performed in a Community
More informationDownloaded from journal.qums.ac.ir at 6: on Monday September 3rd 2018
The Journal of Qazvin Univ. of Med. Sci. No. 31, Summer 2004 - - * Assessment of mutual impact of different sodium citrate concentrations and minimum specimen volume on the result of routine coagulation
More informationEvaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Evaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates JON ATH AN
More informationThe Effectiveness of ASAP Education and Rehabilitation Programs
The Effectiveness of ASAP Education and Rehabilitation Programs James L. Nichols 1 EDUCATIONAL PROGRAMS B ackground and D escription Educational programs for convicted drinking drivers have recently received
More informationLong-Term French Experience in INR Standardization by a Procedure Using Plasma Calibrants
COAGULATION AND TRANSFUSION MEDICINE Long-Term French Experience in Standardization by a Procedure Using Plasma Calibrants LUCIE L. HOUBOUYAN, MD, AND ALAIN F. GOGUEL, MD The International Normalized Ratio
More informationInterpretation of Breathalyser Results for Medico-Legal Purposes
Interpretation of Breathalyser Results for Medico-Legal Purposes - AN INVESTIGATION OF THE BLOOD ALCOHOL CONCENTRATION OF SUBJECTS MONITORED IN A SERIES OF CONTROLLED DRINKING EXPERIMENTS I. E. C. Cameron3
More informationEffects o f Oral Salt Load on Arginine-Vasopressin Secretion in N orm al Subjects*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 5 Copyright 1987, Institute for Clinical Science, Inc. Effects o f Oral Salt Load on Arginine-Vasopressin Secretion in N orm al Subjects* LETIZIA
More informationThrombosis. Clinical Chemistry 51: (2005) Hemostasis and
Clinical Chemistry 51:3 561 568 (2005) Hemostasis and Thrombosis Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio
More informationImpaired Platelet Function Associated witn Parenteral Nafcillin*
ANNALS O F CLIN ICAL AND LABORATORY SCIEN CE, Vol. 20, No. 1 Copyright 1990, Institute for Clinical Science, Inc. Impaired Platelet Function Associated witn Parenteral Nafcillin* ELAINE K. JETER, M.D.,
More informationA Hemoglobin A1C Immunoassay Method Not Affected By Carbamylated Hemoglobin*
ANNALS O F CLIN ICA L AND LABORATORY SCIEN CE, Vol. 25, No. 1 Copyright 1995, Institute for Clinical Science, Inc. A Hemoglobin A1C Immunoassay Method Not Affected By Carbamylated Hemoglobin* ANDREA M.
More informationImmunologic Parameters in Down s Syndrome
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 1 Copyright 1978, Institute for Clinical Science Immunologic Parameters in Down s Syndrome PATRICIA F. JACOBS, M.S., NICHOLAS M. BURDASH, Ph.D.,*
More informationEDUCATIONAL COMMENTARY ORAL ANTICOAGULANT THERAPEUTIC MONITORING AND POINT-OF-CARE TESTING
POINT-OF-CARE TESTING Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Continuing Education on
More informationInfluence of Methodology on Glycosylated Hemoglobin Values in Nigerian Subjects with Sickle Cell Hemoglobinopathy
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 14, No. 4 Copyright 1984, Institute for Clinical Science, Inc. Influence of Methodology on Glycosylated Hemoglobin Values in Nigerian Subjects with Sickle
More informationEffects of Drugs (Other than A lcohol) on Road Safety in V ictoria
Effects of Drugs (Other than A lcohol) on Road Safety in V ictoria J o h n R ic h a r d so n M P V ic to ria n P a rlia m e n t R o ad S a fe ty C o m m itte e, S p rin g S tre e t, M e lb o u rn e 3 0
More informationSerum Cholesterol Methodology: 100 Years of Development*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 20, No. 1 Copyright 1990, Institute for Clinical Science, Inc. Serum Cholesterol Methodology: 100 Years of Development* BRADLEY E. COPELAND, M.D. Department
More informationCA-549: Immunohistochemistry and Serum Levels in Breast Carcinoma and Other Neoplasms*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 19, No. 6 Copyright 1989, Institute for Clinical Science, Inc. CA-549: Immunohistochemistry and Serum Levels in Breast Carcinoma and Other Neoplasms* MUHAMMAD
More informationAnalysis of Two Types of Granulocyte Transfusions in Patients with Acute Leukemia and Septicemia
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 2 Copyright 1982, Institute for Clinical Science, Inc. Analysis of Two Types of Granulocyte Transfusions in Patients with Acute Leukemia and Septicemia
More informationA Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase and Hydroxyproline Assays
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 2 Copyright 1978, Institute for Clinical Science A Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com A STUDY OF PHARMACIST INTERVENTION IN ANTI COAGULATION CLINIC IN A TERTIARY CARE HOSPITAL, BANGLORE, INDIA Mahdieh
More informationCollection of Blood Specimens by Venipuncture for Plasma-Based Coagulation Assays Necessity of a Discard Tube
Coagulation and Transfusion Medicine / Discard Tube Unnecessary for Coagulation Assays Collection of Blood Specimens by Venipuncture for Plasma-Based Coagulation Assays Necessity of a Discard Tube Maarten
More informationPathological Evaluation of WR Administered Orally in Irradiated and Non-Irradiated Male Mice
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 3 Copyright > 1992, Institute for Clinical Science, Inc. Pathological Evaluation of WR-151327 Administered Orally in Irradiated and Non-Irradiated
More informationIsokinetic Measurement of Sagittal Plane Trunk Strength in Older Adults
Grand Valley State University ScholarWorks@GVSU Masters Theses Graduate Research and Creative Practice 5-1993 Isokinetic Measurement of Sagittal Plane Trunk Strength in Older Adults Ralph L. Bidwell Grand
More informationHemostasis Test Validation, Performance and Reference Intervals
Hemostasis Test Validation, Performance and Reference Intervals Richard A. Marlar, Ph.D. Pathology and Laboratory Medicine Oklahoma City VA Medical Center University of Oklahoma Health Sciences Center
More informationAcquired von Willebrand s Disease Following Bone Marrow Transplantation*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 3 Copyright 1994, Institute for Clinical Science, Inc. Acquired von Willebrand s Disease Following Bone Marrow Transplantation* JOHN LAZARCHICK,
More informationInternal Quality Control in the Haemostasis laboratory. Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation
Internal Quality Control in the Haemostasis laboratory Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation Why do we need Quality control? Philadelphia Enquirer Aug
More informationHemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 6 Copyright 1993, Institute for Clinical Science, Inc. Hemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
More informationThis review focuses on the laboratory and near patient
College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy Laboratory Monitoring of Oral Anticoagulant Therapy Robert B. Fairweather, MD, PhD; Jack Ansell, MD; Anton
More informationHemoglobin Alc and Diabetes Mellitus
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 10, No. 2 Copyright 1980, Institute for Clinical Science, Inc. Hemoglobin Alc and Diabetes Mellitus HYMAN ROCHM AN, P h.d., M.D. Department o f Pathology,
More informationWHAT IS EARLY START AND WHY IT SHOULD NOT BE SYSTEMATIC? Christian Com be, Bordeaux, France
WHAT IS EARLY START AND WHY IT SHOULD NOT BE SYSTEMATIC? Christian Com be, Bordeaux, France Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France Prof Christian Combe Servic e de N éphrologie
More informationAnticoagulation in Special populations. Ng Heng Joo Department of Haematology Singapore General Hospital
Anticoagulation in Special populations Ng Heng Joo Department of Haematology Singapore General Hospital roymatheson.com Objectives Safer anticoagulation for The elderly Chronic kidney disease Obese patients
More informationBest Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation
Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation Pratima Patel, PharmD Clinical Pharmacist Medicine Rotation Preceptor Sharp Chula Vista Medical Center
More information6 semanas de embarazo. Critical pt inr levels. Inicio / Embarazo / 6 semanas de embarazo
Inicio / Embarazo / 6 semanas de embarazo 6 semanas de embarazo Critical pt inr levels INR is the result of the patient PT/mean normal PT, exponentially equalized by the ISI. INR levels above 4.9 are considered
More informationLight Microscopical Examination of Glomerular Basement Membrane in Systemic Lupus Erythematosus
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 1 Copyright 1978, Institute for Clinical Science Light Microscopical Examination of Glomerular Basement Membrane in Systemic Lupus Erythematosus J.
More informationOral Factor Xa Inhibitors and Clinical Laboratory Monitoring
Oral Factor Xa Inhibitors and Clinical Laboratory Monitoring MELISSA L. WHITE ABSTRACT Oral anticoagulation therapy is currently undergoing great changes with the development and use of several new medications.
More information1990s DTI. 1980s LMWH
1930s Heparin Parenteral Narrow therapeutic index Unpredictable Monitoring HIT Bleeding risk 1950s Warfarin Narrow therapeutic index Unpredictable Drug interactions Monitoring Bleeding risk 1980s LMWH
More informationSerum Calcitonin in Thyroid Disorders and in Pheochromocytoma Kindred*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 16, No. 2 Copyright 1986, Institute for Clinical Science, Inc. Serum Calcitonin in Thyroid Disorders in Pheochromocytoma Kindred* F. J. H ORNICEK, P H.D.,t$
More informationAcute and Chronic Toxic Nephropathies
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 3 Copyright 1989, Institute for Clinical Science, Inc. Acute and Chronic Toxic Nephropathies M. M ELINDA SANDERS, M.D. and ANNE P. M ARSHALL, M.D.
More informationBehavior of Prothrombin Time (INR) in Response to Warfarin Therapy in a Thai Population
Behavior of Prothrombin Time (INR) in Response to Warfarin Therapy in a Thai Population Sarana Boonbaichaiyapruck,MD, FACC* Pradit Panchavinnin,MD.** Taworn Suthichaiyakul,MD.*** Thanawat Benjanuwatra,MD.****
More informationDiagnostic Indices of Zinc Deficiency in Children with Renal Diseases*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 11, No. 5 Copyright 1981, Institute for Clinical Science, Inc. Diagnostic Indices of Zinc Deficiency in Children with Renal Diseases* RICHARD L. SIEGLER,
More informationReferrals for abnormal coagulation profiles are common
A Practical Approach to Pediatric Patients Referred With an Abnormal Coagulation Profile Monica Acosta, MD; Rachel Edwards, BS; E. Ian Jaffe, MD; Donald L. Yee, MD; Donald H. Mahoney, MD; Jun Teruya, MD,
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY
More informationSENSITIVITY OF DIFFERENT THROMBOPLASTIN REAGENTS TO FACTOR VII DEFICIENCY IN THE BLOOD OF BEAGLE DOGS
Laboratory Animals (1970) 4, 55-59. 55 SENSITIVITY OF DIFFERENT THROMBOPLASTIN REAGENTS TO FACTOR VII DEFICIENCY IN THE BLOOD OF BEAGLE DOGS by D. E. HALL Biological Research Department, BDH (Research)
More informationA Percent Correction Formula for Evaluation of Mixing Studies
Coagulation and Transfusion Medicine / A PERCENT CORRECTION FORMULA FOR EVALUATION OF MIXING STUDIES A Percent Correction Formula for Evaluation of Mixing Studies Sheng-hsiung Chang, MD, Veronica Tillema,
More informationDataDerm Quality Measures
01 MIPS 224 NQF 0562 DataDerm Quality s Melanoma: Overutilization of Imaging Studies 02 a & b MIPS 138 Melanoma: Coordination of Care 03 MIPS 137 NQF 0650 Melanoma: Continuity of Care Recall System Percentage
More information"DENTAL MANAGEMENT OF A PATIENT TAKING ANTICOAGULANTS"
"DENTAL MANAGEMENT OF A PATIENT TAKING ANTICOAGULANTS" ------------------------------------------------------------------------ LT J.D. Molinaro, DC, USN 11 August 2000 Introduction Any patient receiving
More informationNEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS
NEW/NOVEL ORAL ANTICOAGULANTS (NOACS): COMPARISON AND FREQUENTLY ASKED QUESTIONS OBJECTIVES: To provide a comparison of the new/novel oral anticoagulants (NOACs) currently available in Canada. To address
More informationDisclosures. Point of Care Testing (POCT) for Anticoagulation Monitoring. Point of Care Anticoagulation Monitoring. Questions.
Point of Care Testing (POCT) for Anticoagulation Monitoring Paula J. Santrach MD Consultant, Division of Transfusion Medicine Associate Professor, Laboratory Medicine Mayo Clinic Rochester, M Disclosures
More informationHealth and traffic safety behaviors in the U.S.A :
Health and traffic safety behaviors in the U.S.A : 1985-1992 David Shinar*, Richard Com pton** and Edward M ilton *Ben Gurion University of the Negev, Israel **National Highway Traffic Safety Administration,
More informationErythrocyte Uroporphyrinogen I Synthase Activity as an Indicator of Acute Porphyria
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Erythrocyte Uroporphyrinogen I Synthase Activity as an Indicator
More informationAngiotensin-1-Converting Enzyme Activity As Index of Pulmonary Damage in Thermal Injury with or without Smoke Inhalation
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 1 Copyright 1992, Institute for Clinical Science, Inc. Angiotensin-1-Converting Enzyme Activity As Index of Pulmonary Damage in Thermal Injury with
More informationAntithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 20, No. 4 Copyright 1990, Institute for Clinical Science, Inc. Antithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani* G.
More informationA New Methodfor the Rapid A nalysis of Ethanol in Breath, Blood, Urine and Saliva Using the A Icolmeter Evidential Instrument
A New Methodfor the Rapid A nalysis of Ethanol in Breath, Blood, Urine and Saliva Using the A Icolmeter Evidential Instrument T. P. Jones,a A. W. Jones and P. M. Williams INTRODUCTION The introduction
More informationUsing the Variability of INRs to indicate the Risk of an Event in DAWN AC
Predicting Clinical Events Using the Variability of INRs to indicate the Risk of an Event in DAWN AC Syd Stewart, Managing Director, 4S DAWN Clinical Software Introduction It is widely agreed that neither
More informationEvaluation Report. Eurolyser PT (INR) test kit (ST0180) on CUBE and smart analysers
Evaluation Report Eurolyser PT test kit (ST0180) on CUBE and smart analysers Locations Location 1: Eurolyser Diagnostica GmbH Operator: Simone Wieser Date: 30.06.2015 Specimens The specimens used for analysis
More informationReferences: Murtagh J. Murtagh s General Practice. 5 th edn. Sydney: McGraw Hill; 2010.
This presentation is designed to be delivered to people who work in a health care setting; such as nurses, carers and other nursing home staff. If you are an accredited pharmacist, you can use this presentation
More informationGUIDELINES FOR MANAGEMENT OF OVER ANTICOAGULATION WITH WARFARIN
GUIDELINES FOR MANAGEMENT OF OVER ANTICOAGULATION WITH WARFARIN Version Date Purpose of Issue/Description of Change Review Date 1 29/11/05 New Policy December 2007 2 Oct 07 Review Oct 09 3 March 10 Review
More informationThe Effect of Metal Chelators on Lipid Peroxidation in Irradiated Erythrocytes
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 6 Copyright 1992, Institute for Clinical Science, Inc. The Effect of Metal Chelators on Lipid Peroxidation in Irradiated Erythrocytes JOSEPH A. KNIGHT,
More informationThe Effect of Varying Weightload Intensities on Biceps Curl Technique
Western Michigan University ScholarWorks at WMU Master's Theses Graduate College 12-1992 The Effect of Varying Weightload Intensities on Biceps Curl Technique Jeffrey C. Gailhouse Western Michigan University
More informationADMINISTRATIVE CLINICAL Page 1 of 6
ADMINISTRATIVE CLINICAL Page 1 of 6 Anticoagulant Guidelines #2: REVERSAL OF OR MANAGEMENT OF BLEEDING WITH ANTICOAGULANTS Origination Date: Revision Date: Reviewed Date: 09/12 09/12, 01/13, 11/13, 11/15
More informationEvaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System
Evaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System Grace DeSantis, PhD Lisa Croner, PhD Michealle Havenhill, BA Shari Kipp, BSc (Honours) MBA Inverness Medical,
More informationAlterations in von Willebrand Factor Antigen in Premature Infants with Respiratory Distress Syndrome and Chronic Lung Disease*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 1 Copyright 1993, Institute for Clinical Science, Inc. Alterations in von Willebrand Factor Antigen in Premature Infants with Respiratory Distress
More information